# Study Of KITE-753 in R/R B-Cell ALL

> **NCT07674823** · PHASE1 · NOT_YET_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 18 (estimated)

## Conditions studied

- B-cell Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** KITE-753

## Key facts

- **NCT ID:** NCT07674823
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-31
- **Primary completion:** 2029-04-01
- **Final completion:** 2031-04-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07674823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07674823, "Study Of KITE-753 in R/R B-Cell ALL". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07674823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*